eglumetad has been researched along with Anxiety Neuroses in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pilc, A | 1 |
Holden, C | 1 |
Dunayevich, E; Erickson, J; Landbloom, R; Levine, L; Schoepp, DD; Tollefson, GD | 1 |
1 review(s) available for eglumetad and Anxiety Neuroses
Article | Year |
---|---|
LY-354740 (Eli Lilly).
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Bridged Bicyclo Compounds; Clinical Trials as Topic; Excitatory Amino Acid Agonists; Humans; Receptors, Metabotropic Glutamate | 2003 |
1 trial(s) available for eglumetad and Anxiety Neuroses
Article | Year |
---|---|
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder.
Topics: Adult; Alanine; Analysis of Variance; Anxiety Disorders; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Excitatory Amino Acid Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome | 2008 |
1 other study(ies) available for eglumetad and Anxiety Neuroses
Article | Year |
---|---|
Psychiatric drugs. Excited by glutamate.
Topics: Animals; Anxiety Disorders; Brain; Brain Diseases; Bridged Bicyclo Compounds; Clinical Trials as Topic; Depressive Disorder; Dopamine; Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Neurons; Pain; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance-Related Disorders; Synaptic Transmission | 2003 |